Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
Anshika Goenka, Deanna Tiek, Xiao Song, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 484-484
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Glioma: molecular signature and crossroads with tumor microenvironment
Lennart Barthel, Martin Hadamitzky, Philipp Dammann, et al.
Cancer and Metastasis Reviews (2021) Vol. 41, Iss. 1, pp. 53-75
Open Access | Times Cited: 137
Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 122
Conjugation of Macrophage-Mimetic Microalgae and Liposome for Antitumor Sonodynamic Immunotherapy via Hypoxia Alleviation and Autophagy Inhibition
Gao Cheng, Cheryl H. T. Kwong, Qingfu Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4034-4049
Closed Access | Times Cited: 80
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets
José I. Erices, Carolina Bizama, Ignacio Niechi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7047-7047
Open Access | Times Cited: 57
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 30
The tumour microenvironment, treatment resistance and recurrence in glioblastoma
Jasmine White, Madeleine P. J. White, Agadha Wickremesekera, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics
Prakash Gangadaran, Akanksha Onkar, Ramya Lakshmi Rajendran, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Molecular Mechanisms of Drug Resistance in Glioblastoma
М. А. Дымова, Elena V. Kuligina, Vladimir A. Richter
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6385-6385
Open Access | Times Cited: 82
New Directions in the Therapy of Glioblastoma
Katarzyna Szklener, Marek Mazurek, Małgorzata Wieteska, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5377-5377
Open Access | Times Cited: 59
Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
Karl J. Habashy, Rana Mansour, Charbel Moussalem, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 6, pp. 976-987
Open Access | Times Cited: 46
The influence of the blood–brain barrier in the treatment of brain tumours
Sneha Rathi, Jessica I. Griffith, Wenjuan Zhang, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 1, pp. 3-30
Closed Access | Times Cited: 41
Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma
Haibin Wu, Chengcheng Guo, Chaoye Wang, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2609-2621
Open Access | Times Cited: 36
Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance
Frank Eckerdt, Leonidas C. Platanias
Cancers (2023) Vol. 15, Iss. 13, pp. 3458-3458
Open Access | Times Cited: 36
Modern approaches to glioblastoma therapy
Natalya S. Kuznetsova, S. V. Gurova, А. С. Гончарова, et al.
South Russian Journal of Cancer (2023) Vol. 4, Iss. 1, pp. 52-64
Open Access | Times Cited: 24
A Systematic Review and Meta-Analysis of Supramarginal Resection versus Gross Total Resection in Glioblastoma: Can We Enhance Progression-Free Survival Time and Preserve Postoperative Safety?
Johannes Wach, Martin Vychopen, Andreas Kühnapfel, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1772-1772
Open Access | Times Cited: 24
Emerging nanoplatforms towards microenvironment-responsive glioma therapy
Nigam Sekhar Tripathy, Liza Sahoo, Safal Kumar Paikray, et al.
Medical Oncology (2025) Vol. 42, Iss. 2
Closed Access | Times Cited: 1
Hypoxia, a key factor in the immune microenvironment
Jingyao Hu, Xinyu Li, Liang Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113068-113068
Open Access | Times Cited: 31
BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 18
Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation
Carolina Castillo, Maddalena Grieco, Stefania D’Amone, et al.
Cancer Letters (2024) Vol. 588, pp. 216792-216792
Closed Access | Times Cited: 7
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma
Tomás Duraj, Miriam Kalamian, Giulio Zuccoli, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors
Hyunhee Kim, Ka Young Lim, Jin Woo Park, et al.
Laboratory Investigation (2021) Vol. 102, Iss. 2, pp. 160-171
Open Access | Times Cited: 35
Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
Yancheng Lai, Xiaole Lu, Yankai Liao, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 874-889
Open Access | Times Cited: 15
UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway
Yang Wang, Ge Gao, Xiangpin Wei, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 1357-1369
Open Access | Times Cited: 14
Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq
Meng Huang, Shao Xu, Yuzhe Li, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 13
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
Tzu‐Jen Kao, Chien-Liang Lin, Wen‐Bin Yang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top